1e9b
From Proteopedia
(Difference between revisions)
m (Protected "1e9b" [edit=sysop:move=sysop]) |
|||
| Line 1: | Line 1: | ||
| - | [[Image:1e9b.png|left|200px]] | ||
| - | |||
{{STRUCTURE_1e9b| PDB=1e9b | SCENE= }} | {{STRUCTURE_1e9b| PDB=1e9b | SCENE= }} | ||
| + | ===Human thymidylate kinase complexed with AZTMP and APPNP=== | ||
| + | {{ABSTRACT_PUBMED_11071809}} | ||
| - | == | + | ==About this Structure== |
| + | [[1e9b]] is a 1 chain structure with sequence from [http://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1E9B OCA]. | ||
| - | + | ==See Also== | |
| - | == | + | *[[Thymidylate kinase|Thymidylate kinase]] |
| - | [[ | + | |
==Reference== | ==Reference== | ||
| - | <ref group="xtra">PMID:011071809</ref><references group="xtra"/> | + | <ref group="xtra">PMID:011071809</ref><references group="xtra"/><references/> |
| - | [[Category: | + | [[Category: Human]] |
[[Category: DTMP kinase]] | [[Category: DTMP kinase]] | ||
[[Category: Brundiers, R.]] | [[Category: Brundiers, R.]] | ||
| Line 19: | Line 19: | ||
[[Category: Ostermann, N.]] | [[Category: Ostermann, N.]] | ||
[[Category: Padiyar, S.]] | [[Category: Padiyar, S.]] | ||
| - | [[Category: | + | [[Category: Reintein, J.]] |
[[Category: Schlichting, I.]] | [[Category: Schlichting, I.]] | ||
[[Category: Veit, T.]] | [[Category: Veit, T.]] | ||
| Line 25: | Line 25: | ||
[[Category: Phosphotransferase]] | [[Category: Phosphotransferase]] | ||
[[Category: Thymidylate kinase]] | [[Category: Thymidylate kinase]] | ||
| + | [[Category: Transferase]] | ||
Revision as of 15:06, 19 February 2014
Contents |
Human thymidylate kinase complexed with AZTMP and APPNP
Template:ABSTRACT PUBMED 11071809
About this Structure
1e9b is a 1 chain structure with sequence from Human. Full crystallographic information is available from OCA.
See Also
Reference
- Ostermann N, Lavie A, Padiyar S, Brundiers R, Veit T, Reinstein J, Goody RS, Konrad M, Schlichting I. Potentiating AZT activation: structures of wild-type and mutant human thymidylate kinase suggest reasons for the mutants' improved kinetics with the HIV prodrug metabolite AZTMP. J Mol Biol. 2000 Nov 17;304(1):43-53. PMID:11071809 doi:10.1006/jmbi.2000.4175
